• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼功能、功能障碍及其在包括危重病在内的疾病中的作用。

Bone function, dysfunction and its role in diseases including critical illness.

机构信息

Center of Bone Metabolism and Repair, State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.

Bone Research Program, ANZAC Research Institute, The University of Sydney, Hospital Road, Sydney, NSW 2139, Australia.

出版信息

Int J Biol Sci. 2019 Jan 29;15(4):776-787. doi: 10.7150/ijbs.27063. eCollection 2019.

DOI:10.7150/ijbs.27063
PMID:30906209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6429025/
Abstract

The skeleton is one of the largest organs in the human body. In addition to its conventional functions such as support, movement and protection, the skeleton also contributes to whole body homeostasis and maintenance of multiple important non-bone organs/systems (extraskeletal functions). Both conventional and extraskeletal functions of the skeleton are defined as . Bone-derived factors (BDFs) are key players regulating bone function. In some pathophysiological situations, including diseases affecting bone and/or other organs/systems, the disorders of bone itself and the subsequently impaired functions of extraskeletal organs/systems caused by abnormal bone (impaired extraskeletal functions of bone) are defined as . In critical illness, which is a health status characterized by the dysfunction or severe damage of one or multiple important organs or systems, the skeleton shows rapid bone loss resulting from bone hyper-resorption and impaired osteoblast function. In addition, the dysfunctions of the skeleton itself are also closely related to the severity and prognosis of critical illness. Therefore, we propose that there is bone dysfunction in critical illness. Some methods to inhibit osteoclast activity or promote osteoblast function by the treatment of bisphosphonates or PTH1-34 benefit the outcome of critical illness, which indicates that enhancing bone function may be a potential novel strategy to improve prognosis of diseases including critical illness.

摘要

骨骼是人体最大的器官之一。除了支持、运动和保护等传统功能外,骨骼还有助于全身内稳态和维持多个重要的非骨骼器官/系统(骨骼外功能)。骨骼的传统和骨骼外功能都被定义为骨骼疾病。骨骼来源的因子(BDFs)是调节骨骼功能的关键因素。在某些病理生理情况下,包括影响骨骼和/或其他器官/系统的疾病,骨骼本身的紊乱以及由此引起的骨骼外器官/系统功能受损(骨骼外功能受损)被定义为骨骼疾病。在危重病中,一种以一个或多个重要器官或系统功能障碍或严重损伤为特征的健康状态,骨骼会出现快速骨丢失,这是由于骨高吸收和破骨细胞功能受损所致。此外,骨骼本身的功能障碍也与危重病的严重程度和预后密切相关。因此,我们提出在危重病中存在骨骼功能障碍。通过使用双磷酸盐或 PTH1-34 抑制破骨细胞活性或促进成骨细胞功能的一些方法有益于危重病的转归,这表明增强骨骼功能可能是改善包括危重病在内的疾病预后的一种潜在新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/5b27b6a4fff0/ijbsv15p0776g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/0aa2e34bf28f/ijbsv15p0776g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/a54463ff3c69/ijbsv15p0776g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/bbcc06c15458/ijbsv15p0776g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/5b27b6a4fff0/ijbsv15p0776g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/0aa2e34bf28f/ijbsv15p0776g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/a54463ff3c69/ijbsv15p0776g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/bbcc06c15458/ijbsv15p0776g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/6429025/5b27b6a4fff0/ijbsv15p0776g004.jpg

相似文献

1
Bone function, dysfunction and its role in diseases including critical illness.骨骼功能、功能障碍及其在包括危重病在内的疾病中的作用。
Int J Biol Sci. 2019 Jan 29;15(4):776-787. doi: 10.7150/ijbs.27063. eCollection 2019.
2
Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.甲状旁腺激素与双膦酸盐对成骨细胞样细胞系UMR-106调节破骨细胞活性的作用之间的相互作用。
Bone. 1996 Oct;19(4):339-45. doi: 10.1016/s8756-3282(96)00184-6.
3
Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.成骨细胞与破骨细胞的共培养受到聚(D,L-丙交酯)植入物涂层中唑来膦酸局部应用的影响。
J Biomed Mater Res A. 2009 Oct;91(1):288-95. doi: 10.1002/jbm.a.32245.
4
Overview of bisphosphonates.双膦酸盐概述。
Cancer. 1997 Oct 15;80(8 Suppl):1652-60. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z.
5
A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix.基于成骨细胞衍生的天然细胞外基质的破骨细胞功能新型吸收分析。
J Cell Biochem. 2010 Apr 1;109(5):1025-32. doi: 10.1002/jcb.22485.
6
Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.双膦酸盐通过直接作用于早期破骨细胞前体来抑制骨吸收,而不影响成骨细胞的破骨细胞生成能力:蛋白质香叶基香叶基化在含氮双膦酸盐对破骨细胞前体作用中的作用。
Bone. 2002 Jan;30(1):64-70. doi: 10.1016/s8756-3282(01)00655-x.
7
In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.氯膦酸盐、帕米膦酸盐和唑来膦酸对大鼠破骨细胞及人干细胞来源成骨细胞作用的体外比较
Basic Clin Pharmacol Toxicol. 2005 Dec;97(6):382-91. doi: 10.1111/j.1742-7843.2005.pto_176.x.
8
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.破骨细胞介导的骨吸收机制——新型治疗药物设计的理论依据
Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. doi: 10.1016/j.addr.2004.12.018. Epub 2005 Apr 15.
9
Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts.血管活性肠肽通过破骨细胞和成骨细胞上的特异性结合位点调节破骨细胞活性。
Bone. 2000 Dec;27(6):803-10. doi: 10.1016/s8756-3282(00)00394-x.
10
Bone resorptive activity of human peripheral blood mononuclear cells after fusion with polyethylene glycol.人外周血单个核细胞与聚乙二醇融合后的骨吸收活性
J Bone Miner Metab. 2017 Mar;35(2):127-141. doi: 10.1007/s00774-016-0744-0. Epub 2016 Mar 11.

引用本文的文献

1
Extracellular Vesicle-Integrated Biomaterials in Bone Tissue Engineering Applications: Current Progress and Future Perspectives.骨组织工程应用中细胞外囊泡整合生物材料:当前进展与未来展望
Int J Nanomedicine. 2025 Jun 17;20:7653-7683. doi: 10.2147/IJN.S522198. eCollection 2025.
2
Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis.利用纳米科学与战略交付推动骨质疏松症研究进展
AAPS PharmSciTech. 2025 May 9;26(5):129. doi: 10.1208/s12249-025-03120-9.
3
Exploring the Science of Shape: How Physical Activity, Sleep, and Stress Affect Body Composition.

本文引用的文献

1
Treatment of Osteoporosis, with a Focus on 2 Monoclonal Antibodies.骨质疏松症的治疗,重点关注 2 种单克隆抗体。
Med Sci Monit. 2018 Dec 3;24:8758-8766. doi: 10.12659/MSM.912309.
2
Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi).维生素 D、甲状旁腺激素(PTH)和磷酸盐(Pi)对磷酸盐的生理调节。
Pflugers Arch. 2019 Jan;471(1):83-98. doi: 10.1007/s00424-018-2231-z. Epub 2018 Nov 5.
3
FGF23 beyond Phosphotropic Hormone.成纤维细胞生长因子 23 超越磷酸盐激素。
探索形状的科学:身体活动、睡眠和压力如何影响身体成分。
Healthcare (Basel). 2025 Apr 20;13(8):949. doi: 10.3390/healthcare13080949.
4
Basketball's Improvement in Bone Mineral Density Compared to Other Sports or Free Exercise Practice in Children and Adolescents: A Systematic Review and Meta-Analysis.篮球运动对儿童和青少年骨矿物质密度的改善作用与其他运动或自由锻炼的比较:一项系统评价和荟萃分析
Children (Basel). 2025 Feb 24;12(3):271. doi: 10.3390/children12030271.
5
Temporal Profiling of Cellular and Molecular Processes in Osteodifferentiation of Dental Pulp Stem Cells.牙髓干细胞成骨分化过程中细胞和分子过程的时间特征分析
Biology (Basel). 2025 Mar 4;14(3):257. doi: 10.3390/biology14030257.
6
Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics.整合空间转录组学和单细胞转录组学绘制人类骨组织的空间图谱。
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1298.
7
A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.探讨 2 型糖尿病(T2DM)和肥胖症中骨健康的动物模型综述。
Int J Mol Sci. 2024 Aug 29;25(17):9399. doi: 10.3390/ijms25179399.
8
Correction to "Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration".对《纳米纤维微球:骨组织再生的仿生平台》的修正
ACS Appl Bio Mater. 2024 Sep 16;7(9):6325-6331. doi: 10.1021/acsabm.4c01057. Epub 2024 Aug 20.
9
Mechanical loading on osteocytes regulates thermogenesis homeostasis of brown adipose tissue by influencing osteocyte-derived exosomes.骨细胞上的机械负荷通过影响骨细胞衍生的外泌体来调节棕色脂肪组织的产热稳态。
J Orthop Translat. 2024 Jul 26;48:39-52. doi: 10.1016/j.jot.2024.06.012. eCollection 2024 Sep.
10
Differences in intestinal and renal Ca and P uptake in three different breeds of growing-finishing pigs.三种不同生长育肥猪品种在肠道和肾脏钙磷吸收上的差异。
Vet Q. 2024 Dec;44(1):1-16. doi: 10.1080/01652176.2024.2371609. Epub 2024 Jul 4.
Trends Endocrinol Metab. 2018 Nov;29(11):755-767. doi: 10.1016/j.tem.2018.08.006. Epub 2018 Sep 11.
4
Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts.骨的旁分泌和内分泌作用——成骨细胞、骨细胞和破骨细胞分泌蛋白的功能
Bone Res. 2018 May 24;6:16. doi: 10.1038/s41413-018-0019-6. eCollection 2018.
5
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.成纤维细胞生长因子 23 与危重症患者的死亡相关。
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.
6
Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism.成骨细胞中 Vhl 的缺失会促进细胞糖酵解,并改善整体葡萄糖代谢。
J Clin Invest. 2018 Mar 1;128(3):1087-1105. doi: 10.1172/JCI97794. Epub 2018 Feb 12.
7
Osteocalcin in the brain: from embryonic development to age-related decline in cognition.脑内骨钙素:从胚胎发育到与年龄相关的认知能力下降。
Nat Rev Endocrinol. 2018 Mar;14(3):174-182. doi: 10.1038/nrendo.2017.181. Epub 2018 Jan 29.
8
Genetics of Osteopetrosis.成骨不全症的遗传学。
Curr Osteoporos Rep. 2018 Feb;16(1):13-25. doi: 10.1007/s11914-018-0415-2.
9
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.骨硬化蛋白通过调节脂肪细胞的分解代谢和合成代谢来影响身体成分。
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11238-E11247. doi: 10.1073/pnas.1707876115. Epub 2017 Dec 11.
10
Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers.危重症中免疫器官功能障碍的评估:固有免疫反应标志物的效用
Intensive Care Med Exp. 2017 Oct 23;5(1):49. doi: 10.1186/s40635-017-0163-0.